4th Quarter - Report
PODESTA GROUP, INC. for AMPHASTAR PHARMACEUTICALS, INC.
Firm
Income
$80,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
FDA Reform Abbreviated New Drug Application (ANDA) process and Follow-on-Biologics
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELE BAIERLEIN New | — |
| RANDALL GERARD | Senate Commerce, Science & Transportation |
| ANDREW J LEWIN New | Leg. Asst & Director, Rep. Max Sandlin |
| ANTHONY PODESTA New | — |
| NICOLE C YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.